Langer R C, Riggs M W
Department of Veterinary Science and Microbiology, University of Arizona, Tucson, Arizona 85721, USA.
Infect Immun. 1999 Oct;67(10):5282-91. doi: 10.1128/IAI.67.10.5282-5291.1999.
Cryptosporidiosis, caused by the apicomplexan parasite Cryptosporidium parvum, has become a well-recognized diarrheal disease of humans and other mammals throughout the world. No approved parasite-specific drugs, vaccines, or immunotherapies for control of the disease are currently available, although passive immunization with C. parvum-specific antibodies has some efficacy in immunocompromised and neonatal hosts. We previously reported that CSL, an approximately 1,300-kDa conserved apical glycoprotein of C. parvum sporozoites and merozoites, is the antigenic species mechanistically bound by neutralizing monoclonal antibody 3E2 which elicits the circumsporozoite precipitate (CSP)-like reaction and passively protects against C. parvum infection in vivo. These findings indicated that CSL has a functional role in sporozoite infectivity. Here we report that CSL has properties consistent with being a sporozoite ligand for intestinal epithelial cells. For these studies, native CSL was isolated from whole sporozoites by isoelectric focusing (IEF) following observations that the approximately 1,300-kDa region containing CSL as seen by sodium dodecyl sulfate-polyacrylamide gel electrophoresis was comprised of approximately 15 molecular species (pI 3 to 10) when examined by two-dimensional (2-D) electrophoresis and silver staining. A subset of six approximately 1,300-kDa species (pI 4.0 to 6.5) was specifically recognized by 3E2 in 2-D Western immunoblots of IEF-isolated CSL. Isolated native CSL bound specifically and with high affinity to permissive human intestinal epithelial Caco-2 cells in a dose-dependent, saturable, and self-displaceable manner. Further, CSL specifically bound to the surface of live Caco-2 cells inhibited sporozoite attachment and invasion. In addition, sporozoites having released CSL after incubation with 3E2 and occurrence of the CSP-like reaction did not attach to and invade Caco-2 cells. These findings indicate that CSL contains a sporozoite ligand which facilitates attachment to and invasion of Caco-2 cells and, further, that ligand function may be disrupted by CSL-reactive monoclonal antibody. We conclude that CSL is a rational target for passive or active immunization against cryptosporidiosis.
隐孢子虫病由顶复门寄生虫微小隐孢子虫引起,已成为全球范围内人类和其他哺乳动物中一种广为人知的腹泻病。目前尚无用于控制该病的经批准的针对寄生虫的药物、疫苗或免疫疗法,尽管用微小隐孢子虫特异性抗体进行被动免疫在免疫受损宿主和新生宿主中具有一定疗效。我们之前报道过,CSL是微小隐孢子虫子孢子和裂殖子中一种约1300 kDa的保守顶端糖蛋白,是与中和性单克隆抗体3E2发生机制性结合的抗原种类,该抗体可引发环子孢子沉淀(CSP)样反应,并在体内被动预防微小隐孢子虫感染。这些发现表明CSL在子孢子感染性方面具有功能性作用。在此我们报道,CSL具有与作为肠道上皮细胞子孢子配体相符的特性。对于这些研究,在观察到十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳所见的包含CSL的约1300 kDa区域在二维(2 - D)电泳和银染检测时由约15种分子种类(pI 3至10)组成后,通过等电聚焦(IEF)从全子孢子中分离出天然CSL。在IEF分离的CSL的二维Western免疫印迹中,3E2特异性识别了六个约1300 kDa种类(pI 4.0至6.5)的一个子集。分离出的天然CSL以剂量依赖性、可饱和且可自身置换的方式特异性且高亲和力地结合到允许的人肠道上皮Caco - 2细胞上。此外,CSL特异性结合到活Caco - 2细胞表面可抑制子孢子的附着和侵袭。另外,与3E2孵育后释放CSL并出现CSP样反应的子孢子不会附着并侵袭Caco - 2细胞。这些发现表明CSL包含一种子孢子配体,其促进子孢子对Caco - 2细胞的附着和侵袭,并且进一步表明配体功能可能被CSL反应性单克隆抗体破坏。我们得出结论,CSL是针对隐孢子虫病进行被动或主动免疫的合理靶点。